These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12513833)

  • 1. [p21(WAF1) transfection decreases sensitivity of K562 cells to VP-16].
    Yang H; Wang SW; Yin HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):31-4. PubMed ID: 12513833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [P21(WAF1) inhibits the growth of leukemia cell line K562 and decreases its sensitivity to Vp16].
    Yang H; Wang S; Yin H
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):19-22. PubMed ID: 12015083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p21(WAF1) Gene Transfection Inhibits Proliferation of Leukemia Cell Line K562].
    Yang H; Wang SW; Yin HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Jun; 9(2):115-118. PubMed ID: 12578615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
    Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide].
    Ruan GR; Chen SS; Chang Y; Li JL; Qin YZ; Li LD; Hao L; Fu JY; Liu YR; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):936-40. PubMed ID: 17956665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergetic cytotoxicity of cisplatin and etoposide to leukemia cell line K562 and its mechanism].
    Ma WD; Yin MY; Jiang CW; Xu SR; Zhai LD; Zheng LF; Wang YL; Yan YL
    Ai Zheng; 2005 Aug; 24(8):958-64. PubMed ID: 16086873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
    Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
    Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression.
    Satou M; Aizawa S; Hayakari M; Ookawa K; Tsuchida S
    Cancer Sci; 2003 Mar; 94(3):286-91. PubMed ID: 12824923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1).
    Upadhyay S; Neburi M; Chinni SR; Alhasan S; Miller F; Sarkar FH
    Clin Cancer Res; 2001 Jun; 7(6):1782-9. PubMed ID: 11410520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
    Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic killing effect of the conditionally replicating adenoviruses carrying programmed cell death 5 gene and etoposide on K562 cells].
    Xie M; Chang Y; Niu JH; Zhang Y; Li JL; Wu HP; Li LF; Huang XJ; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1435-9. PubMed ID: 21176346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
    Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.
    Gong Y; Deng S; Zhang M; Wang G; Minuk GY; Burczynski F
    Br J Cancer; 2002 Feb; 86(4):625-9. PubMed ID: 11870547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental research on tyrosine-kinase inhibitor STI571 and P21WAF gene clone to treat chronic myeloid leukemia].
    Wang W; Sun BZ; Liu XP; Feng Q; Shang ZC; Cao YX; Yao LB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):737-42. PubMed ID: 15631651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.